The prevalence of hereditary haemochromatosis in a diabetic population

QJM: An International Journal of Medicine

Volumn 90, Issue 4, 1997, Pages 271-275

  Turnbull, A J ^a,c   Mitchison, H C ^a   Peaston, R T P ^a   Lai, L C ^a   Bennett, M K ^a   Taylor, R ^b   Bassendine, M F ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c YORK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; DIABETES MELLITUS; FEMALE; HEMOCHROMATOSIS; HISTOLOGY; HUMAN; IRON BLOOD LEVEL; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; STEATOSIS; TEACHING HOSPITAL; UNITED KINGDOM;

EID: 0030889134     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.4.271     Document Type: Article

References (31)

1. Simon M, Brissot P. The genetics of haemochromatosis. J Hepatol 1988; 6:116-24.
2. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313:1256-62.
3. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary haemochromatosis. Gastroenterology 1991; 101:368-72.
4. Fargion S, Mandelli C, Piperno A, Cesara B, Fracanzani AL, Fraquelli M, Bianchi PA, et al. Survival and prognostic factors in 212 Italian patients with genetic haemochromatosis. Hepatology 1992; 15:655-9.
5. Finlayson NDC. Hereditary (primary) haemochromatosis. Br Med J 1990; 301:350-1.
6. Phelps G, Chapman I, Hall P, Braund W, MacKinnon M. Prevalence of Genetic Haemochromatosis among diabetic patients. Lancet 1989; 2:233-4.
7. O'Brien T, Barrett B, Murray DM, Dinneen S, O'Sullivan DJ. Usefulness of biochemical screening of diabetic patients for hemochromatosis. Diabetes Care 1990; 13:532-4
8. Singh BM, Grunewald RA, Press M, Muller BR, Wise PH. Prevalence of haemochromatosis amongst patients with diabetes mellitus. Diabetic Medicine 1992; 9:730-1.
9. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, et al. A novel MHC Class 1-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics 1996; 13:399-408.
10. Scheuer PJ. Liver Biopsy Interpretation, 4th edn. London, Bailliere Tindall, 1988:211.
11. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6:24-9.
12. Summers K, Halliday J, Powell L. Identification of homozygous haemochromatosis subjects by measurement of biochemical hepatic iron index. Hepatology 1990; 12:20-5.
13. Bonkosky HL, Slaker D, Bills E, Wolf D. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease. Gastroenterology 1990; 99:1080-91.
14. Olsson KS, Ritter B, Rosén U, Heedman PA, Staugård F. Prevalence of iron overload in central Sweden. Acta Med Scand 1983; 213:145-50
15. Borwein ST, Ghent C N, Flanagan PR, Chamberlain MJ, Valberg LS. Genetic expression of haemochromatosis in Canadians. Clin Invest Med 1983; 6:171-9.
16. Brind AM, Bassendine MF. Molecular genetics of chronic liver diseases. Bailliere's Clin Gastroenterol 1990; 4:233-49.
17. Bonkosky HL, Ponka P, Bacon BR, Drysdale J, Grace ND, Tavill AS. An update on iron metabolism: Summary of the fifth international conference on disorders of iron metabolism. Hepatology 1996; 24:718-29.
18. Wiggers P, Dalhøj J, Hyltoft Petersen P, Blaabjerg O, Hørder M. Screening for haemochromatosis: influence of analytical imprecision, diagnostic limit and prevalence on test validity. Scand J Clin Lab Invest 1991; 51:143-8.
19. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988; 318:1355-62.
20. Kaye TB, Guay AT, Simonson DC. Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. J Diabetes Complications 1993; 7:246-9.
21. Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: Predictive accuracy of biochemical screening tests. Gastroenterology 1984; 87:628-33.
22. Beilby J, Olynyk J, Ching S, Prins A, Swanson N, Reed W, Harley H, Garcia-Webb P. Transferrin index: An alternative method for calculating the iron saturation of transferrin. Clin Chem 1992; 38/10:2078-81.
23. Crawford DHG, Powell LW, Leggat BA, Francis JS, Fletcher LM, Webb SI, Halliday JW, Jazwinska EC. Evidence that the ancestral haplotype in Australian haemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 1995; 57:362-7.
24. Saudek CD, Charache S. Haemochromatosis and diabetes. Bailliere's Clin Endocrinol Metab 1992; 6:807-17.
25. Dean JCS, Pearson DWM, Powrie JK. Prevalence of Genetic Haemochromatosis in diabetic patients. Lancet 1989; ii:925.
26. Cundy TF. Prevalence of Genetic Haemochromatosis in diabetic patients. Lancet 1989; ii:925.
27. Leevy CM, Ryan CM, Fineberg JC. Diabetes mellitus and liver dysfunction: Etiologic and therapeutic considerations. Am J Med 1950; 8:290-9.
28. Van Thiel DH. Diabetes mellitus and hepatobiliary disease. Current Concepts in Gastroenterology 1985; 2:3-11.
29. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 12:1106-10.
30. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11:74-80.
31. Haemochromatosis...definite maybe! Editorial. Nature Genetics 1996; 13:375-6.